Supplementary Table S3 from Integration of Whole-Genome Sequencing Analysis with Unique Patient-Derived Models Reveals Clinically Relevant Drug Targets in TFCP2 Fusion–Defined Rhabdomyosarcoma
收藏数据链接：
官方服务：
资源简介：
Supplementary Table S3 shows the antibodies and staining conditions used for immunohistochemistry analyses of patient and PDX tumor tissue.
创建时间：
2025-12-02
